This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bachwich, P. R. Articles by Kunkel, S. L. Search for Related Content PubMed PubMed Citation Articles by Bachwich, P. R. Articles by Kunkel, S. L.

American Journal of Pathology, Vol 125, 421-425, Copyright © 1986 by American Society for Investigative Pathology

REGULAR ARTICLES

Tumor necrosis factor production by human sarcoid alveolar macrophages

PR Bachwich, JP Lynch 3d, J Larrick, M Spengler and SL Kunkel

Tumor necrosis factor (TNF) is an oncolytic peptide that may also exert many other biologic effects. Experimentally, immunologically activated mononuclear phagocytes stimulated with endotoxin (LPS) produce TNF, while resting mononuclear phagocytes stimulated with LPS produce little TNF. To date, the ability of human alveolar macrophages (AMs) to produce TNF has not been clearly delineated. As pulmonary sarcoidosis is a granulomatous inflammatory disorder characterized by immunologically activated AMs, we investigated the production of TNF by AMs obtained by bronchoalveolar lavage from 7 normal volunteers and 13 patients with pulmonary sarcoidosis. The AMs were cultured with and without LPS, and TNF production was assessed by an in vitro cytotoxicity assay. Unstimulated sarcoid and normal AMs produced little TNF, but LPS stimulation enhanced TNF production by both normal and sarcoid AMs. Furthermore, LPS-stimulated sarcoid AMs produced more TNF than normal AMs (84.9 +/- 16.7 versus 32.5 +/- 10.2 units/million cells, P less than 0.05). It is concluded that human AMs can produce TNF and that sarcoid AMs are primed and can produce significantly more TNF, compared with normal AMs.

This article has been cited by other articles:

				C. Colp, M. Stein, L. Angeles, and CA Re-emergence of an "Orphan" Test for Pulmonary Embolism Chest, July 1, 2001; 120(1): 5 - 6. [Full Text] [PDF]

				G.M. Verleden, R.M. du Bois, D. Bouros, M. Drent, A. Millar, J. Muller-Quernheim, G. Semenzato, S. Johnson, G. Sourvinos, D. Olivieri, et al. Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin Eur. Respir. J., July 1, 2001; 18(32_suppl): 17S - 29s. [Abstract] [Full Text] [PDF]

				L. Armstrong, N. M Foley, and A. B Millar Inter-relationship between tumour necrosis factor-alpha (TNF-alpha ) and TNF soluble receptors in pulmonary sarcoidosis Thorax, June 1, 1999; 54(6): 524 - 530. [Abstract] [Full Text]

				A. K. Shetty and A. Gedalia Sarcoidosis: A Pediatric Perspective Clinical Pediatrics, December 1, 1998; 37(12): 707 - 717. [Abstract] [PDF]

				E. Sato, S. Koyama, Y. Okubo, K. Kubo, and M. Sekiguchi Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity Am J Physiol Lung Cell Mol Physiol, June 1, 1998; 274(6): L970 - L979. [Abstract] [Full Text] [PDF]

				L. P. Nicod and P. Isler Alveolar Macrophages in Sarcoidosis Coexpress High Levels of CD86 (B7.2), CD40, and CD30L Am. J. Respir. Cell Mol. Biol., July 1, 1997; 17(1): 91 - 96. [Abstract] [Full Text]